77.59
2.89%
2.14
Overview
News
Price History
Option Chain
Financials
Why LRCX Down?
Discussions
Forecast
Stock Split
Dividend History
Lam Research Corp stock is traded at $77.59, with a volume of 4.76M.
It is up +2.89% in the last 24 hours and down -6.14% over the past month.
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
See More
Previous Close:
$75.45
Open:
$75.85
24h Volume:
4.76M
Relative Volume:
0.37
Market Cap:
$97.79B
Revenue:
$15.59B
Net Income/Loss:
$4.06B
P/E Ratio:
2.6382
EPS:
29.41
Net Cash Flow:
$4.84B
1W Performance:
+6.34%
1M Performance:
-6.14%
6M Performance:
-16.42%
1Y Performance:
+32.92%
Lam Research Corp Stock (LRCX) Company Profile
Name
Lam Research Corp
Sector
Phone
(510) 659-0200
Address
4650 CUSHING BLVD, FREMONT, CA
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-25-24 | Reiterated | TD Cowen | Outperform |
Jan-23-24 | Initiated | Cantor Fitzgerald | Neutral |
Dec-12-23 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-22-23 | Initiated | Redburn Atlantic | Buy |
Oct-17-23 | Initiated | Raymond James | Outperform |
Oct-13-23 | Upgrade | Needham | Hold → Buy |
Sep-15-23 | Initiated | Wolfe Research | Outperform |
Jul-24-23 | Reiterated | Mizuho | Buy |
Jul-24-23 | Upgrade | Stifel | Hold → Buy |
Apr-20-23 | Reiterated | Berenberg | Buy |
Apr-20-23 | Reiterated | Evercore ISI | Outperform |
Apr-20-23 | Reiterated | JP Morgan | Overweight |
Apr-20-23 | Reiterated | Jefferies | Buy |
Apr-20-23 | Reiterated | Mizuho | Buy |
Apr-20-23 | Reiterated | Stifel | Hold |
Apr-20-23 | Reiterated | Wells Fargo | Equal Weight |
Mar-13-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
Jan-18-23 | Resumed | Stifel | Hold |
Dec-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
Oct-20-22 | Reiterated | B. Riley Securities | Neutral |
Oct-20-22 | Reiterated | BofA Securities | Buy |
Oct-20-22 | Reiterated | DA Davidson | Neutral |
Oct-20-22 | Reiterated | Evercore ISI | Outperform |
Oct-20-22 | Reiterated | JP Morgan | Overweight |
Oct-20-22 | Reiterated | Jefferies | Buy |
Oct-20-22 | Upgrade | Summit Insights | Hold → Buy |
Oct-20-22 | Reiterated | Wells Fargo | Equal Weight |
Jul-25-22 | Downgrade | Barclays | Overweight → Equal Weight |
Jun-15-22 | Downgrade | B. Riley Securities | Buy → Neutral |
Jan-27-22 | Reiterated | Barclays | Overweight |
Jan-27-22 | Reiterated | Deutsche Bank | Hold |
Jan-27-22 | Reiterated | Evercore ISI | Outperform |
Jan-27-22 | Reiterated | Stifel | Buy |
Jan-27-22 | Reiterated | Susquehanna | Neutral |
Jan-27-22 | Reiterated | UBS | Buy |
Jan-26-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jan-12-22 | Reiterated | Barclays | Overweight |
Jan-10-22 | Reiterated | BofA Securities | Buy |
Jan-05-22 | Resumed | Jefferies | Buy |
Dec-15-21 | Reiterated | Deutsche Bank | Hold |
Oct-21-21 | Reiterated | B. Riley Securities | Buy |
Oct-21-21 | Downgrade | Summit Insights | Buy → Hold |
Oct-15-21 | Initiated | Piper Sandler | Neutral |
Sep-14-21 | Downgrade | Susquehanna | Positive → Neutral |
Sep-07-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Jul-29-21 | Reiterated | Mizuho | Buy |
Jul-29-21 | Reiterated | Stifel | Buy |
Jul-29-21 | Reiterated | UBS | Buy |
Jul-29-21 | Reiterated | Wells Fargo | Equal Weight |
Mar-31-21 | Initiated | Bernstein | Outperform |
Jan-28-21 | Reiterated | Cowen | Outperform |
Jan-08-21 | Downgrade | Needham | Buy → Hold |
Dec-17-20 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-22-20 | Reiterated | Goldman | Buy |
Oct-22-20 | Reiterated | KeyBanc Capital Markets | Overweight |
Oct-22-20 | Reiterated | Mizuho | Buy |
Oct-22-20 | Reiterated | Morgan Stanley | Overweight |
Oct-22-20 | Reiterated | RBC Capital Mkts | Outperform |
Oct-22-20 | Reiterated | Stifel | Buy |
Oct-22-20 | Reiterated | UBS | Buy |
Sep-21-20 | Upgrade | Stifel | Hold → Buy |
Jul-30-20 | Reiterated | Cowen | Outperform |
Jul-21-20 | Upgrade | B. Riley FBR | Neutral → Buy |
Jun-22-20 | Downgrade | Stifel | Buy → Hold |
Jun-16-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
May-26-20 | Initiated | Barclays | Overweight |
Apr-23-20 | Reiterated | Needham | Buy |
Apr-08-20 | Initiated | Exane BNP Paribas | Outperform |
Apr-03-20 | Upgrade | Nomura | Neutral → Buy |
Apr-02-20 | Downgrade | DA Davidson | Buy → Neutral |
Mar-27-20 | Upgrade | Deutsche Bank | Hold → Buy |
Mar-27-20 | Upgrade | UBS | Sell → Buy |
View All
Lam Research Corp Stock (LRCX) Latest News
Lam Research Co. (NASDAQ:LRCX) Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Lam Research beats Q1 expectations, shares jump on strong outlook - MSN
Lam Research (NASDAQ:LRCX) Shares Down 0.9%Time to Sell? - MarketBeat
Lam Research Co. (NASDAQ:LRCX) Shares Sold by First Financial Bankshares Inc - MarketBeat
Lam Research beats Q1 expectations, shares rise on strong outlook - MSN
Lam Research Proves Analysts Wrong with a Strong Earnings Report - MSN
Riding The Wave: The Case For Investing In Lam Research Amid Memory Industry Resurgence - Seeking Alpha
Lam Research (NASDAQ:LRCX) Shares Up 2.8%Here's Why - MarketBeat
Cullinan Associates Inc. Has $79.16 Million Holdings in Lam Research Co. (NASDAQ:LRCX) - MarketBeat
B. Riley Has Negative Outlook for Lam Research Q2 Earnings - MarketBeat
Lam Research (LRCX) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance
Lam Research's SWOT analysis: semiconductor stock faces China headwinds - Investing.com
Lam Research (NASDAQ:LRCX) Trading 3.8% Higher on Better-Than-Expected Earnings - MarketBeat
Lam Research (NASDAQ:LRCX) PT Lowered to $85.00 at Wells Fargo & Company - MarketBeat
Lam Research Q1 Earnings Beat: Can Strong Q2 Guidance Lift The Stock? - Barchart
Lam Earnings: Demand Looks Solid After a Strong Quarter, and We Maintain Our $83 Valuation - Morningstar
Lam Research Q1 Earnings Beat: Can Strong Q2 Guidance Lift the Stock? - Yahoo Finance
Lam Research's (LRCX) Neutral Rating Reiterated at Cantor Fitzgerald - MarketBeat
Lam Research Q1 results impress analysts, but questions over China remain - MSN
Lam Research Corporation (NASDAQ:LRCX) Q1 2025 Earnings Call Transcript - Insider Monkey
Lam Research Q1 results impress analysts, but questions over China remain (LRCX) - Seeking Alpha
Lam Research Corp (LRCX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Industry ... - Yahoo Finance
Lam Research: Fiscal Q1 Earnings Snapshot - Houston Chronicle
Lam Research (LRCX) PT Lowered to $75 at Deutsche Bank - StreetInsider.com
Lam Research Corp (LRCX) Q3 Earnings: EPS of $0.86 Beats Estimates, Revenue Hits $4.17 Billion - GuruFocus.com
Lam Research Corp. stock falls Wednesday, still outperforms market - MarketWatch
Lam Research (NASDAQ:LRCX) Q3: Beats On Revenue, Stock Soars - Yahoo Finance
Lam Research beats Q1 expectations, shares rise on strong outlook By Investing.com - Investing.com South Africa
Lam Research just reported Q1 results. Here's why the stock is rising. (LRCX) - Seeking Alpha
Lam Research Corporation Reports Financial Results for the Quarter Ended September 29, 2024 - PR Newswire
Lam Research (NASDAQ:LRCX) Shares Up 0.2%Should You Buy? - MarketBeat
Lam Research (NASDAQ:LRCX) Price Target Cut to $77.00 by Analysts at Morgan Stanley - MarketBeat
Jim Cramer on Lam Research Corporation (LRCX): ‘I Think It’ll Tell A Good Story’ - Insider Monkey
Lam Research Corp. stock rises Tuesday, outperforms market - MarketWatch
Lam Research (NASDAQ:LRCX) Trading Down 0.6%What's Next? - MarketBeat
Why Lam Research Is At A Make-Or-Break Level Before Earnings (NASDAQ:LRCX) - Seeking Alpha
Nvidia Stock Investors Have a Significant Wednesday Coming Up - The Motley Fool
Lam Research shares retain Buy rating at B.Riley, with target cut due to NAND weakness - Investing.com
Why You Should Care About Lam Research's (NASDAQ:LRCX) Strong Returns On Capital - Yahoo Finance
Lam Research (LRCX) Q3 Earnings: What To Expect - Yahoo Finance
Lam Research (NASDAQ:LRCX) Trading Down 0.4%Here's What Happened - MarketBeat
Should You Buy, Sell or Hold Lam Research Stock Before Q1 Earnings? - Yahoo Finance
Q3 EPS Estimates for Lam Research Cut by Zacks Research - MarketBeat
Lam Research Corp Stock (LRCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):